PF
The startup has developed a medical device that modifies human plasma by removing pepsinogen, a protein linked to the fibrinolytic system, to enhance coagulation properties. This technology enables healthcare professionals to obtain blood and plasma products that are more effective in treating massive bleeding.
Updated 18 months ago
Funding
$2.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a medical device that modifies human plasma by removing pepsinogen, a protein linked to the fibrinolytic system, to enhance coagulation properties. This technology enables healthcare professionals to obtain blood and plasma products that are more effective in treating massive bleeding.